Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Heart and Vascular Institute, 2799 W Grand Blvd., Detroit, MI 48202, USA.
Circ Heart Fail. 2011 Jan;4(1):65-70. doi: 10.1161/CIRCHEARTFAILURE.110.955013. Epub 2010 Nov 19.
Autonomic abnormalities exist in heart failure and contribute to disease progression. Activation of the carotid sinus baroreflex (CSB) has been shown to reduce sympathetic outflow and augment parasympathetic vagal tone. This study tested the hypothesis that long-term electric activation of the CSB improves left ventricular (LV) function and attenuates progressive LV remodeling in dogs with advanced chronic heart failure.
Studies were performed in 14 dogs with coronary microembolization-induced heart failure (LV ejection fraction ≈25%). Eight dogs were chronically instrumented for bilateral CSB activation using the Rheos System (CVRx Inc, Minneapolis, Minn) and 6 were not and served as controls. All dogs were followed for 3 months, and none received other background therapy. During follow-up, treatment with CSB increased LV ejection fraction 4.0±2.4% compared with a reduction in control dogs of −2.8±1.0% (P<0.05). Similarly, treatment with CSB decreased LV end-systolic volume -2.5±2.7 mL compared with an increase in control dogs of 6.7±2.9 mL (P<0.05). Compared with control, CSB activation significantly decreased LV end-diastolic pressure and circulating plasma norepinephrine, normalized expression of cardiac β(1)-adrenergic receptors, β-adrenergic receptor kinase, and nitric oxide synthase and reduced interstitial fibrosis and cardiomyocyte hypertrophy.
In dogs with advanced heart failure, CSB activation improves global LV function and partially reverses LV remodeling both globally and at cellular and molecular levels.
自主神经异常存在于心力衰竭中,并促进疾病进展。激活颈动脉窦压力反射(CSB)已被证明可以减少交感神经输出并增强副交感神经迷走神经张力。本研究检验了这样一个假设,即长期电激活 CSB 可以改善患有晚期慢性心力衰竭的犬的左心室(LV)功能并减轻进行性 LV 重塑。
这项研究在 14 只患有冠状动脉微栓塞诱导性心力衰竭的狗(LV 射血分数≈25%)中进行。8 只狗使用 Rheos 系统(CVRx Inc,明尼苏达州明尼阿波利斯)进行双侧 CSB 激活的慢性仪器化,而 6 只狗没有进行仪器化作为对照。所有狗都随访了 3 个月,没有接受其他背景治疗。在随访期间,与对照组狗的减少相比,CSB 治疗使 LV 射血分数增加了 4.0±2.4%(P<0.05)。同样,CSB 治疗使 LV 收缩末期容积减少了 2.5±2.7 毫升,而对照组狗的 LV 收缩末期容积增加了 6.7±2.9 毫升(P<0.05)。与对照组相比,CSB 激活显著降低了 LV 舒张末期压力和循环血浆去甲肾上腺素,使心脏β(1)-肾上腺素能受体、β-肾上腺素能受体激酶和一氧化氮合酶的表达正常化,并减少了间质纤维化和心肌细胞肥大。
在患有晚期心力衰竭的犬中,CSB 激活可改善整体 LV 功能,并在整体和细胞及分子水平部分逆转 LV 重塑。